Papers
2
Total Citations
28
H-Index
2
About
Hope Feldman is a leading thoracic surgeon and translational researcher whose work bridges surgical oncology and immunotherapy for lung cancer. Her landmark 2023 study, cited 19 times, investigated surgical outcomes following neoadjuvant chemotherapy combined with nivolumab, with or without ipilimumab, in non-small cell lung cancer patients—a pivotal contribution to the evolving landscape of perioperative immunotherapy. This work has helped define optimal surgical timing and safety profiles for patients receiving these powerful checkpoint inhibitors. Additionally, her research on persistent opioid use after lung cancer resection, which has garnered 9 citations, addresses a critical public health concern by examining how surgical approach influences long-term pain management in Medicare patients. Dr. Feldman’s investigations into the intersection of novel systemic therapies and surgical technique are shaping clinical guidelines and improving outcomes for lung cancer patients. Her work is particularly notable for its focus on real-world, high-risk populations, ensuring that advances in immunotherapy translate into safer, more effective surgical care.
Research Focus
Key Achievements
Top Papers
- 1
- 2